• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Malaria Drug Pipeline Capsule - 2012 Product Image

Global Malaria Drug Pipeline Capsule - 2012

  • Published: January 2012
  • Region: Global
  • 13 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Malaria Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global malaria drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, READ MORE >

1. Malaria: Disease Definition
2. Malaria Drug Pipeline Overview
3. Malaria Phase 3 Clinical Trial Drug Pipeline Insights
4. Malaria Phase 2 Clinical Trial Drug Pipeline Insights
5. Malaria Phase 1 Clinical Trial Drug Pipeline Insights
6. Malaria Preclinical Research Drug Pipeline Insights
7. Malaria Drug Discovery Pipeline Insights
8. Geographic Landscape of Malaria R&D Activities
8.1 Malaria R&D Activities in North America
8.2 Malaria R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Malaria Drug Market
10 Research Methodology
Table 1: Malaria Drug Pipeline: Phase 3 Clinical Trial
Table 2: Malaria Drug Pipeline: Phase 2 Clinical Trial
Table 3: Malaria Drug Pipeline: Phase 1 Molecules
Table 4: Malaria Drug Pipeline: Preclinical Research
Table 5: Malaria R&D Activities by Geography
Table 6: Malaria Drug Pipeline: North America
Table 7: Malaria Drug Pipeline: Europe
Table 8: Malaria Drug Pipeline: Licensing Activities
Figure 1 : Malaria Drug Pipeline Molecules by Stages
Figure 2 : Malaria R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos